Does a Mandatory Non-Medical Switch From Originator to Biosimilar Infliximab Lead to Increased Use of Outpatient Healthcare Resources? A Register-Based Study in Patients With Inflammatory Arthritis
RMD Open - United Kingdom
doi 10.1136/rmdopen-2018-000710
Full Text
Open PDFAbstract
Available in full text
Date
July 1, 2018
Authors
Publisher
BMJ